Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt cap
Decision snapshot: DDS stock price vs ALL: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ALL's multiple
Needs ALL P/E.
Implied fair value · at DDS's multiple
Needs DDS P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple premium
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: DDS FY 2026 (ended Jan 31, 2026) · ALL FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 104% equity / -4% debt · EV / Revenue 1.37x · EV / EBITDA 12.93x
Capital structure 90% equity / 10% debt · EV / Revenue 1.00x · EV / EBITDA 4.95x
ALL carries the larger enterprise value at $67.56B against $8.99B; ALL trades on the lower EV / Revenue multiple (1.00x vs 1.37x); ALL on the lower EV / EBITDA (4.95x vs 12.93x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
DILLARD’S, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
ALLSTATE CORP · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
-0.23x
0.24x
Net debt / EBITDA
Leverage against operating earnings
-1.82x
0.14x
Cash and equivalents
Liquid reserves on the balance sheet
$861.46M
$5.57B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Macy's, Inc.
DDS vs M
KOHLS Corp
DDS vs KSS
TJX COMPANIES INC /DE/
DDS vs TJX
NORDSTROM INC
DDS vs JWN
AMERICAN INTERNATIONAL GROUP, INC.
DDS vs AIG
TRAVELERS COMPANIES, INC.
DDS vs TRV
PROGRESSIVE CORP/OH/
DDS vs PGR
Chubb Ltd
DDS vs CB
HARTFORD FINANCIAL SERVICES GROUP, INC.
DDS vs HIG
BERKSHIRE HATHAWAY INC
DDS vs BRK-B
-$402.20M
$7.49B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
